METHYS Dx
PrivateLast Round
Crowdfunding
May 13, 2026
Est. Valuation
$7.87M
Total Funding Raised
$1.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
METHYS Dx operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Crowdfunding round in May 2026.
METHYS Dx is a biotechnology company that develops personalized medicine solutions for oncology through non-invasive liquid biopsy monitoring techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
METHYS Dx Comparables
Compare METHYS Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alercell, Inc. | 83% | |
| Harbinger Health | 79% | |
| Precision Epigenomics | 78% |
For institutional investors. Book with your work email.
METHYS Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | May 13, 2026 | ||||
| Grant | Jul 5, 2023 | ||||
| Pre Seed | May 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
METHYS Dx Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 26% QoQ from 19 to 24 employees.
- Jul 20, 2026
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
METHYS Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about METHYS Dx's valuation, stock price, and market status.
Is METHYS Dx a public or private company?
METHYS Dx is a private company.
What is the current stock price of METHYS Dx?
METHYS Dx is a private company, so its shares have no public market price. Caplight tracks METHYS Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is METHYS Dx worth (valuation)?
METHYS Dx's valuation is estimated at $7.9M based on funding round data.
Can I buy METHYS Dx stock?
METHYS Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was METHYS Dx's last funding round?
METHYS Dx's most recent funding round was Crowdfunding on May 13, 2026.
Who are the main investors in METHYS Dx?
Key investors in METHYS Dx include Erganeo, Bpifrance.
Will METHYS Dx IPO soon?
No public IPO plans have been announced for METHYS Dx.
How can I track METHYS Dx secondary market activity?
Caplight tracks bids, offers, and trades in METHYS Dx's shares on secondary markets.